Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

NCT00599924 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms
Neoplasms

Interventions

DRUG: sunitinib + FOLFOX
DRUG: sunitinib + FOLFOX
DRUG: sunitinib + FOLFOX
DRUG: sunitinib + FOLFOX
DRUG: sunitinib + FOLFOX
DRUG: sunitinib + FOLFOX
DRUG: sunitinib + FOLFOX

Sponsor

Pfizer